The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Induction of Tumors in Mice by Genomic Hypomethylation
Abstract
Genome-wide DNA hypomethylation occurs in many human cancers, but whether this epigenetic change is a cause or consequence of tumorigenesis has been unclear. To explore this phenomenon, we generated mice carrying a hypomorphic DNA methyltransferase 1 ( Dnmt1 ) allele, which reduces Dnmt1 expression to 10% of wild-type levels and results in substantial genome-wide hypomethylation in all tissues. The mutant mice were runted at birth, and at 4 to 8 months of age they developed aggressive T cell lymphomas that displayed a high frequency of chromosome 15 trisomy. These results indicate that DNA hypomethylation plays a causal role in tumor formation, possibly by promoting chromosomal instability.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Reduced DNA methylation (hypomethylation) in mice increases the risk of aneuploidy and cancer (Gaudet et al., 2003)”
From The Aging Epigenome (2016) · cites this paper as Gaudet et al., 2003
In the citing paper
“Indeed, the global DNA hypomethylation, especially occurring on intragenic regions, is a general feature of most tumours [35][36][37] .”
From Intragenic DNA methylation prevents spurious transcription initiation (2017) · cites this paper as [36]
Citations
Cites
Jaenisch, R., & Bird, A. (2003) · Nature Genetics · doi:10.1038/ng1089 · Cited by 6,325
Self-citationThe fundamental role of epigenetic events in cancer
Jones, P. A., & Baylin, S. B. (2002) · Nature Reviews Genetics · doi:10.1038/nrg816 · Cited by 5,648
Targeted mutation of the DNA methyltransferase gene results in embryonic lethality
Li, E., Bestor, T. H., & Jaenisch, R. (1992) · Cell · doi:10.1016/0092-8674(92)90611-f · Cited by 3,984
Self-citationHypomethylation distinguishes genes of some human cancers from their normal counterparts
Feinberg, A. P., & Vogelstein, B. (1983) · Nature · doi:10.1038/301089a0 · Cited by 2,437
Loss of the Suv39h Histone Methyltransferases Impairs Mammalian Heterochromatin and Genome Stability
Peters, A. H. F. M., O'Carroll, D., Scherthan, H., Mechtler, K., Sauer, S., Schöfer, C., Weipoltshammer, K., Pagani, M., Lachner, M., Kohlmaier, A., et al. (2001) · Cell · doi:10.1016/s0092-8674(01)00542-6 · Cited by 1,766
DNA methylation in cancer: too much, but also too little
Ehrlich, M. (2002) · Oncogene · doi:10.1038/sj.onc.1205651 · Cited by 1,538
Chromosomal Instability and Tumors Promoted by DNA Hypomethylation
Eden, A., Gaudet, F., Waghmare, A., & Jaenisch, R. (2003) · Science · doi:10.1126/science.1083557 · Cited by 1,399
Self-citationXu, G.-L., Bestor, T. H., Bourc'his, D., Hsieh, C.-L., Tommerup, N., Bugge, M., Hulten, M., Qu, X., Russo, J. J., & Viegas-Péquignot, E. (1999) · Nature · doi:10.1038/46052 · Cited by 1,203
Transcription of IAP endogenous retroviruses is constrained by cytosine methylation
Walsh, C. P., Chaillet, J. R., & Bestor, T. H. (1998) · Nature Genetics · doi:10.1038/2413 · Cited by 1,105
DNA hypomethylation leads to elevated mutation rates
Chen, R. Z., Pettersson, U., Beard, C., Jackson-Grusby, L., & Jaenisch, R. (1998) · Nature · doi:10.1038/25779 · Cited by 954
Self-citation
Research works printed but not linked: 3
- S. Cory, D. L. Vaux, A. Strasser, A. W. Harris, J. M. Adams, Cancer Res.59 (suppl.), 1685s (1999).
- E. Wainfan, L. A. Poirier, Cancer Res.52, 2071s (1992).
- V. Zagonelet al., Leukemia7 (suppl. 1), 30 (1993).
Cited by
Items 901–1,000 of 1,001
Altered epigenetic signals in human disease
Croce, L. D., Buschbeck, M., Gutiérrez, A., Joval, I., Morey, L., Villa, R., & Minucci, S. (2004) · Cancer Biology & Therapy · doi:10.4161/cbt.3.9.1103 · Cited by 23
Azhikina, T. L., Gainetdinov, I. V., Skvortsova, Y. V., Batrak, A. V., Dmitrieva, N., & Sverdlov, E. D. (2003) · Molecular Genetics and Genomics · doi:10.1007/s00438-003-0959-3 · Cited by 19
Cannuyer, J., Tongelen, A. V., Loriot, A. E., & Smet, C. D. (2015) · Clinical Epigenetics · doi:10.1186/s13148-015-0147-4 · Cited by 19
“DNA hypomethylation was shown to promote tumor development at least in part by increasing genome instability [7].”
BackgroundSuppressive effect of global DNA hypomethylation on gastric carcinogenesis
Tomita, H., Hirata, A., Yamada, Y., Hata, K., Oyama, T., Mori, H., Yamashita, S., Ushijima, T., & Hara, A. (2010) · Carcinogenesis · doi:10.1093/carcin/bgq129 · Cited by 17
Yang, M., Arai, E., Takahashi, Y., Totsuka, H., Chiku, S., Taniguchi, H., Katai, H., Sakamoto, H., Yoshida, T., & Kanai, Y. (2020) · Carcinogenesis · doi:10.1093/carcin/bgaa079 · Cited by 19
“It is feasible that chromosomal instability plays a significant role in the epigenomically defined Cluster B1, since genome-wide DNA methylation alterations generally result in chromosomal instability through aberrant chromatin configurations (43).”
BackgroundTavares, N. T., Gumauskaitė, S., Lobo, J., Jerónimo, C., & Henrique, R. (2022) · Cancers · doi:10.3390/cancers14122918 · Cited by 21
“, tumor suppressor genes (TSG)) hypermethylation [48], global hypomethylation of the cancer genome [49], or direct mutagenesis of 5mC sequences [50,51].”
BackgroundSu, L. J. (2012) · Methods in molecular biology · doi:10.1007/978-1-61779-612-8_24 · Cited by 20
Kastrup, I. B., Worm, J., Ralfkiaer, E. M., Hokland, P., Guldberg, P., & Grønbæk, K. (2007) · European Journal Of Haematology · doi:10.1111/j.1600-0609.2007.00980.x · Cited by 18
“Several lines of nutrition research have demonstrated an association between reduced dietary intake or low tissue ⁄plasma levels of folate and a higher risk for developing cancer (29, 30), and there are at least two main mechanisms by which decreased levels of folate might contribute to tumorigenesis: (i) genomic hypo…”
BackgroundRepeat element-driven activation of proto-oncogenes in human malignancies
Lamprecht, B., Bonifer, C., & Mathas, S. (2010) · Cell Cycle · doi:10.4161/cc.9.21.13682 · Cited by 21
Yin, L., Zhu, Z., Huang, L., Luo, X., Li, Y., Xiao, C., Yang, J., Wang, J., Zou, Q., Tao, L., et al. (2021) · Horticulture Research · doi:10.1038/s41438-021-00576-1 · Cited by 21
Carotta, S., & Nutt, S. L. (2008) · BioEssays · doi:10.1002/bies.20725 · Cited by 25
Preuner, S., Denk, D., Frommlet, F., Neßlboeck, M., & Lion, T. (2008) · Leukemia · doi:10.1038/leu.2008.97 · Cited by 18
Epigenetic Markers of Ovarian Cancer
Barton, C. A., Clark, S. J., Hacker, N. F., & O’Brien, P. M. (2008) · Springer eBooks · doi:10.1007/978-0-387-68969-2_4 · Cited by 17
Epigenetic drugs for cancer treatment and prevention: mechanisms of action
Yu, X., & Guo, Z. S. (2010) · BioMolecular Concepts · doi:10.1515/bmc.2010.020 · Cited by 29
“Epigenetic alterations contribute to carcinogenesis by the basic mechanisms of epigenetic activation of oncogenes (11, 12) or welldocumented epigenetic inactivation of tumor suppressor genes (TSGs) (1–5).”
BackgroundMolecular Mechanisms of Epigenetic Regulators as Activatable Targets in Cancer Theranostics
Li, Y., Li, Z., & Zhu, W. (2019) · Current Medicinal Chemistry · doi:10.2174/0929867324666170921101947 · Cited by 21
Timakhov, R. A., Tan, Y., Rao, M., Liu, Z., Altomare, D. A., Pei, J., Wiest, D. L., Favorova, O. O., Knepper, J. E., & Testa, J. R. (2009) · Genes Chromosomes and Cancer · doi:10.1002/gcc.20683 · Cited by 18
“Trisomy 14 and trisomy 15 have also been reported to be common changes in other studies of T-cell malignancies (Gaudet et al., 2003).”
ResultChromatin: a molecular interface between cancer and aging
Cruickshanks, H. A., & Adams, P. D. (2010) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2010.10.007 · Cited by 17
Mining Methylation for Early Detection of Common Cancers
Brena, R. M., Plass, C., & Costello, J. (2006) · PLoS Medicine · doi:10.1371/journal.pmed.0030479 · Cited by 17
“One hypothesis is that alterations in DNA methylation play a key role in tumor initiation, and if this is true, methylation markers are ideally suited for detecting cancer in the early stages [11,12].”
BackgroundAberrant Promoter Hypomethylation in CLL: Does It Matter for Disease Development?
Upchurch, G. M., Haney, S. L., & Opavský, R. (2016) · Frontiers in Oncology · doi:10.3389/fonc.2016.00182 · Cited by 19
Johnston, H. E., Carter, M. J., Cox, K. L., Dunscombe, M., Manousopoulou, A., Townsend, P. A., Garbis, S. D., & Cragg, M. S. (2017) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m116.063511 · Cited by 17
“5B, 5C) suggests dynamic epigenomic instability as a basis of myc-induced tumor characteristics, previously observed in B-cell lymphomas (56, 57).”
BackgroundFerrarias, T. M., Fernandes, N. C. C. D. A., de Oliveira, T. F., Lopes, P. A., Réssio, R. A., Gonçalves, S., Scattone, N. V., Tedardi, M. V., Kulikowski, L. D., Damasceno, J. G., et al. (2019) · PLoS ONE · doi:10.1371/journal.pone.0211898 · Cited by 18
Interplay between DNA Methyltransferase 1 and microRNAs During Tumorigenesis
Yadav, P., Bandyopadhayaya, S., Ford, B. M., & Mandal, C. C. (2021) · Current Drug Targets · doi:10.2174/1389450122666210120141546 · Cited by 17
DNA methylation pattern of theSLC25A43gene in breast cancer
Lindqvist, B. M., Farkas, S. A., Wingren, S., & Nilsson, T. (2012) · Epigenetics · doi:10.4161/epi.7.3.19064 · Cited by 18
Cell‐cycle regulation of T‐cell responses – novel approaches to the control of alloimmunity
Wells, A. D. (2003) · Immunological Reviews · doi:10.1046/j.1600-065x.2003.00080.x · Cited by 17
“The contribution of epigenetic mechanisms of gene regulation play crucial roles in developmental biology (37) and cancer (38, 39), and their involvement in cell-mediated immunity is becoming appreciated (40, 41).”
BackgroundHsieh, C., & Jones, P. A. (2003) · Nature Cell Biology · doi:10.1038/ncb0603-502 · Cited by 17
Yildiz, C. B., & Zimmer‐Bensch, G. (2022) · Advances in experimental medicine and biology · doi:10.1007/978-3-031-11454-0_15 · Cited by 19
SLC2As as diagnostic markers and therapeutic targets in LUAD patients through bioinformatic analysis
Zhang, Y., Qin, H., Bian, J., Ma, Z., & Yi, H. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1045179 · Cited by 19
“Focusing on how epigenetic alteration affects cancer etiology, both suppressor gene suppression caused by excessive methylation in gene promoters and oncogene activation or chromosomal instability caused by widespread hypomethylation can occur in malignancies (Merlo et al., 1995; Rosty et al., 2002; Gaudet et al., 200…”
BackgroundInduced Pluripotent Stem Cells
Yu, J., & Thomson, J. A. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-398358-9.00030-6 · Cited by 23
Novel risk markers for gastric cancer screening: Present status and future prospects
Enomoto, S. (2010) · World Journal of Gastrointestinal Endoscopy · doi:10.4253/wjge.v2.i12.381 · Cited by 16
Wang, K.-Y., Chen, S. C.-C., Tsai, S., & Shen, C.-K. J. (2016) · Scientific Reports · doi:10.1038/srep37490 · Cited by 18
“Interestingly, levels as low as 10% of normal Dnmt1 amount could sustain mouse development 28 , which prompted us to collect ES clones with different levels of the exogenous proteins for study.”
Epigenetic modulation associated with carcinogenesis and prognosis of human gastric cancer
Sonohara, F., Inokawa, Y., Hayashi, M., Kodera, Y., & Nomoto, S. (2017) · Oncology Letters · doi:10.3892/ol.2017.5912 · Cited by 16
Disruption of circadian clockwork in in vivo reprogramming‐induced mouse kidney tumors
Ohashi, M., Umemura, Y. M., Koike, N., Tsuchiya, Y., Inada, Y., Watanabe, H., Tanaka, T., Minami, Y., Ukimura, O., Miki, T., et al. (2017) · Genes to Cells · doi:10.1111/gtc.12552 · Cited by 16
“…process, that is, abnormalities in a wide range of changes in cell lineage- specific gene expression profiles controlled by epigenetic regulations, may be related to carcinogenesis (Bonasio, Tu, & Reinberg, 2010; Feinberg, 2007; Gaudet et al., 2003; Hikichi et al., 2013; Lee & Young, 2013).”
Emerging DNA methylation inhibitors for cancer therapy: challenges and prospects
González‐Fierro, A., & Dueñas‐González, A. (2019) · Expert Review of Precision Medicine and Drug Development · doi:10.1080/23808993.2019.1571906 · Cited by 16
“phomas and high frequency of chromosome 15 trisomy [37].”
BackgroundConconi, D., Redaelli, S., Lissoni, A. A., Cilibrasi, C., Perego, P., Gautiero, E., Sala, E. M., Paderno, M., Dalprà, L., Landoni, F., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22041580 · Cited by 16
“Even though DNA hypomethylation was the first epigenetic disruption in cancer [29], it took more studies to define its implications in tumorigenesis leading to genomic instability [30], enhanced expression [31], loss of imprinting [32] and abnormal X-chromosome activation [33].”
BackgroundDNA N6-Adenine methylation in HBV-related hepatocellular carcinoma
Cui, H., Rong, W., Ma, J., Zhu, Q. C., Jiang, B., Zhang, L., Li, C., Zhuo, Z., & Chen, M. (2022) · Gene · doi:10.1016/j.gene.2022.146353 · Cited by 15
DNA Methylation Topology: Potential of a Chromatin Landmark for Epigenetic Drug Toxicology
Tajbakhsh, J. (2011) · Epigenomics · doi:10.2217/epi.11.101 · Cited by 16
Tobacco Consumption and Oral, Pharyngeal and Lung Cancers
Bassiony, M., Aqil, M., Khalili, M., Radosevich, J. A., & Elsabaa, H. M. (2015) · The Open Cancer Journal · doi:10.2174/1874079001508010001 · Cited by 19
“Loss of DNA methylation mechanisms are still under investigation and not completely understood [60].”
BackgroundEtzkorn, M., Böckmann, A., Pénin, F., Riedel, D., & Baldus, M. (2006) · Journal of the American Chemical Society · doi:10.1021/ja066469x · Cited by 16
Pongpanich, M., Patchsung, M., Thongsroy, J., & Mutirangura, A. (2014) · BMC Genomics · doi:10.1186/1471-2164-15-750 · Cited by 16
“Firstly, RIND-EDSBs are linked to methylated CpG nucleotides [1], and genomic hypomethylation is associated with genomic instability [11-13].”
Fundamental concepts of epigenetics for consideration in anesthesiology
Naguib, M., Bie, B., & Ting, A. H. (2012) · Current Opinion in Anaesthesiology · doi:10.1097/aco.0b013e3283556211 · Cited by 17
Functional interaction between co-expressed MAGE-A proteins
Laiseca, J. E., Ladelfa, M. F., Cotignola, J., Peche, L. Y., Pascucci, F. A., Castaño, B. A., Galigniana, M. D., Schneider, C., & Monte, M. (2017) · PLoS ONE · doi:10.1371/journal.pone.0178370 · Cited by 16
Transcriptional regulation of metabolism in disease: From transcription factors to epigenetics
Hawkins, L. J., Al-attar, R., & Storey, K. B. (2018) · PeerJ · doi:10.7717/peerj.5062 · Cited by 21
“Methyl-deficiency and subsequent general DNA hypomethylation has long been known to be carcinogenic (Wilson, Shivapurkar & Poirier, 1984; Lin et al., 2001; Gaudet et al., 2003), specifically hypomethylation of oncogenes creates a transcriptional environment in which they can be expressed (Feinberg & Vogelstein, 1983;…”
BackgroundChanda, S., Dasgupta, U. B., Mazumder, D. G., Saha, J., & Gupta, B. (2013) · SpringerPlus · doi:10.1186/2193-1801-2-557 · Cited by 16
“Overall, tumor cell DNA is hypomethylated compared to normal cell DNA and underexpression of Dnmt1 gene causes aggressive tumor induction in genetically engineered mice (Gaudet et al. 2003).”
BackgroundPredicting the effect of transcription therapy in hematologic malignancies
Melnick, A. M. (2005) · Leukemia · doi:10.1038/sj.leu.2403777 · Cited by 16
Recent developments in the biology and therapy of T-cell and natural killer–cell lymphomas
Porcu, P., Baiocchi, R. A., & MAGRO, C. M. J. (2003) · Current Opinion in Oncology · doi:10.1097/00001622-200309000-00002 · Cited by 16
Georges, R. O., Sepúlveda, H., Angel, J. C., Johnson, E., Palomino, S., Nowak, R. B., Desai, A. B., López-Moyado, I. F., & Rao, A. (2022) · Nature Communications · doi:10.1038/s41467-022-33742-7 · Cited by 16
Tumor Dormancy and Reactivation: The Role of Heat Shock Proteins
Amissah, H. A., Combs, S. E., & Shevtsov, M. A. (2024) · Cells · doi:10.3390/cells13131087 · Cited by 15
“Genome-wide hypomethylation, primarily in gene-coding regions and satellite repeats, leads to chromosomal rearrangement and mitotic recombination, causing significant genomic instability that promotes phenotypic heterogeneity, as seen in tumors [52].”
BackgroundForn, M., Díez-Villanueva, A., Merlos‐Suárez, A., Muñoz, M., Lois, S., Carrió, E., Jordà, M., Bigas, A., Batlle, E., & Peinado, M. A. (2015) · PLoS ONE · doi:10.1371/journal.pone.0123263 · Cited by 16
“On the other hand, hypomethylation shows different signatures in differentiation and cancer and is already present in the non-tumor tissue adjacent to the adenomas in Apcmice, which is consistent with a role in the promotion of tumorigenesis [77,78].”
BackgroundLINE-1 activation and epigenetic silencing of suppressor genes in cancer: Causally related events?
Tufarelli, C., Cruickshanks, H. A., & Meehan, R. R. (2013) · Mobile Genetic Elements · doi:10.4161/mge.26832 · Cited by 20
The Application of Delivery Systems for DNA Methyltransferase Inhibitors
Lim, S. P., Neilsen, P. M., Kumar, R., Abell, A. D., & Callen, D. F. (2011) · BioDrugs · doi:10.2165/11592770-000000000-00000 · Cited by 15
Clinical outcome after failure of hypomethylating therapy for myelodysplastic syndrome
Lee, J., Choi, Y., Kim, S.-D., Kim, D., Lee, J., Lee, K., Lee, S., Lee, W., & Joo, Y. (2014) · European Journal Of Haematology · doi:10.1111/ejh.12469 · Cited by 16
Micevic, G., Theodosakis, N., Taube, J. M., Bosenberg, M., & Rodić, N. (2016) · Melanoma Research · doi:10.1097/cmr.0000000000000315 · Cited by 16
Application of Single-Cell Omics in Breast Cancer
Dwivedi, S., Purohit, P., Misra, R., Lingeswaran, M., Vishnoi, J. R., Pareek, P., Sharma, P., & Misra, S. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-817532-3.00005-0 · Cited by 23
Epigenetic Modifications in Ovarian Cancer: A Review
Ashraf, A. H. M. Z., Afroze, S. H., Osuji, G., Kayani, S., Colon, N., Pantho, A. F., Kuehl, T. J., Pilkinton, K. A., & Uddin, M. (2020) · Journal of Cancer Treatment and Diagnosis · doi:10.29245/2578-2967/2020/2.1179 · Cited by 15
Timbergen, M. J. M., Boers, R., Vriends, A. L. M., Boers, J., van IJcken, W. F. J., Lavrijsen, M., Grünhagen, D. J., Verhoef, C. K., Sleijfer, S., Smits, R., et al. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.565031 · Cited by 16
“DNA hypomethylation of gene promoter regions is usually associated with tumor formation, activation of oncogenes, and chromosomal instability (32, 33).”
BackgroundRegulation of the epigenetic landscape by immune cell oxidants
Das, A. B., Seddon, A. R., O'Connor, K. M., & Hampton, M. B. (2021) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2020.12.453 · Cited by 17
Ma, Z., Wang, Y., Quan, Y., Wang, Z., Liu, Y., & Ding, Z. (2022) · Human Genomics · doi:10.1186/s40246-022-00410-2 · Cited by 20
“For instance, since low expression of DNMT1 can reduce 5mC to about 10% of the normal level, DNMT1–deficient mice are more prone to suffer aggressive lymphoma and chromosomal instability [68, 69].”
BackgroundProximity ligation in situ assay for monitoring the global DNA methylation in cells
Hervouet, É., Hulin, P., Vallette, F. M., & Cartron, P. (2011) · BMC Biotechnology · doi:10.1186/1472-6750-11-31 · Cited by 15
“Moreover, several paper reports that the DNA hypomethylation is an oncogenic event leading the chromosomal instability and the oncogenes expression [4,5].”
BackgroundMechanism and clinical significance of cyclooxygenase-2 expression in gastric cancer
Wang, B. (2005) · World Journal of Gastroenterology · doi:10.3748/wjg.v11.i21.3240 · Cited by 15
Xia, B., Pang, L., Zhuang, Z., & Liu, J. (2015) · Toxicology Letters · doi:10.1016/j.toxlet.2015.11.010 · Cited by 15
Morimoto, C. Y., Tedardi, M. V., da Fonseca, I. I. M., Kimura, K. C., Sanches, D. S., Epiphanio, T. F., Strefezzi, R. D. F., & Dagli, M. L. (2016) · Veterinary and Comparative Oncology · doi:10.1111/vco.12241 · Cited by 15
Cai, Y., Lin, J.-R., Zhang, Q., O’Brien, K., Montagna, C., & Zhang, Z. D. (2018) · Scientific Reports · doi:10.1038/s41598-018-24005-x · Cited by 16
Baqir, S., & Smith, L. C. (2006) · Cloning and Stem Cells · doi:10.1089/clo.2006.8.200 · Cited by 18
“DNA hypomethylation is implicated in chromosomal instability and deregulation of imprinted genes leading to carcinogenesis and tumorigenesis (Eden et al., 2003; Feinberg, 2005; Gaudet et al., 2003; Holm et al., 2005; Kim et al., 2004).”
Cell type-dependent, infection-induced, aberrant DNA methylation in gastric cancer
Perrin, D., Ruskin, H. J., & Niwa, T. (2010) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2010.02.040 · Cited by 21
“• Overall hypomethylation, which affects repetitive DNA sequences and causes both chromosomal instability, and, hence, tumours, (Gaudet et al., 2003), as well as aberrant expression of normally methylated genes, (Smet et al.”
BackgroundZhao, Y., Zhang, W., Chen, Y., Fang, F., & Liu, X. (2012) · Maturitas · doi:10.1016/j.maturitas.2012.03.003 · Cited by 15
Gluten-Free Diet, Chromosomal Abnormalities, and Cancer Risk in Coeliac Disease
Verkarre, V., Romana, S. P., & Cerf–Bensussan, N. (2004) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1002/j.1536-4801.2004.tb12130.x · Cited by 15
Wyatt, M. D. (2013) · Advances in cancer research · doi:10.1016/b978-0-12-407190-2.00002-2 · Cited by 16
Relationship between LINE-1 hypomethylation and Helicobacter pylori infection in gastric mucosae
Kosumi, K., Baba, Y., Ishimoto, T., Harada, K., Miyake, K., Izumi, D., Tokunaga, R., Murata, A., Eto, K., Sugihara, H., et al. (2015) · Medical Oncology · doi:10.1007/s12032-015-0571-5 · Cited by 14
Lynch, H. N., Loftus, C. T., Cohen, J. M., Kerper, L. E., Kennedy, E. M., & Goodman, J. E. (2016) · Regulatory Toxicology and Pharmacology · doi:10.1016/j.yrtph.2016.10.006 · Cited by 16
Miyata, T., Yamashita, Y., Baba, Y., Harada, K., Yamao, T., Umezaki, N., Tsukamoto, M., Kitano, Y., Yamamura, K., Arima, K., et al. (2018) · Oncotarget · doi:10.18632/oncotarget.25124 · Cited by 14
“The underlying mechanisms may be as follows: First, global DNA hypomethylation contributes to cancer development by inducing genomic instability [15].”
BackgroundBajpai, M., Kessel, R. M., Bhagat, T. D., Nischal, S., Yu, Y., Verma, A. K., & Das, K. M. (2013) · Genes Chromosomes and Cancer · doi:10.1002/gcc.22106 · Cited by 14
“Epigenetic alterations are common during neoplastic transformation and may precede major genetic changes that lead to cancer (Eden et al., 2003; Gaudet et al., 2003; Feinberg and Tycko, 2004).”
BackgroundLin, W., CEN, Y. L., Lin, Y., Su, F., Wu, B., Tang, L.-Y., & Ren, Z. (2015) · Neoplasma · doi:10.4149/neo_2015_059 · Cited by 14
“597 [56] GAUDET F, HODGSON JG, EDEN A, JACKSON-GRUSBY L, DAUSMAN J, et al.”
BackgroundVilkin, A., & Niv, Y. (2010) · Clinical Epigenetics · doi:10.1007/s13148-010-0013-3 · Cited by 14
“Cancer gene genomes simultaneously show global hypomethylation, specific promoter hypermethylation of tumor suppressor genes, and hypomethylation of oncogenes (Gaudet et al. 2003; Eden et al. 2003; Greger et al. 1989).”
BackgroundMouse models in epigenetics: insights in development and disease
Espada, J., & Esteller, M. (2013) · Briefings in Functional Genomics · doi:10.1093/bfgp/elt005 · Cited by 15
“These mice showed a global DNA demethylation in most tissues associated to the developing of aggressive T-cell lymphomas [63], suggesting that, actually, DNA hypomethylation plays a causal role in tumorogenesis.”
BackgroundRNA‐directed epigenomic reprogramming—an emerging principle of a more targeted cancer therapy?
Moskalev, E. A., Schubert, M., & Hoheisel, J. D. (2011) · Genes Chromosomes and Cancer · doi:10.1002/gcc.20943 · Cited by 14
“1A) and has both positive and negative consequences, such as the clinically favorable temporal reactivation of aberrantly silenced tumor suppressor genes and the adverse effect of inducing proto-oncogenes, pro-metastatic genes, and transposable elements (Gaudet et al., 2003; Howard et al., 2008; Chik and Szyf, 2011).”
BackgroundGenetic signature for human risk assessment: Lessons from trichloroethylene
Shiao, Y. (2008) · Environmental and Molecular Mutagenesis · doi:10.1002/em.20432 · Cited by 18
“…of genome-wide DNA methylation as a result of knockdown of the DNA methyltransferase 1 gene increases the frequency of chromosomal 15 trisomy in T- cell lymphomas [Gaudet et al., 2003] and loss of hetero- zygosity at the Apc locus in liver tumors [Yamada et al., 2005] in experimental animals.”
Khodarev, N. N., Labay, E., Darga, T. E., Yu, J. J., Mauceri, H. J., Gupta, N. M., Kataoka, Y., & Weichselbaum, R. R. (2003) · International Journal of Cancer · doi:10.1002/ijc.11728 · Cited by 14
Chen, F., Zhang, Q., Deng, X., Zhang, X., Chen, C., Lv, D., Li, Y., Li, D., Zhang, Y., Li, P., et al. (2018) · Epigenetics · doi:10.1080/15592294.2018.1500057 · Cited by 16
“Although the inverse correlation between DNA methylation and CpG distribution has been observed in various species [4,14,24], and a deviation of such a correlation would lead to severe disorders [24,27,28,32], no approach is currently available to quantitatively describe this inverse correlation or to locate the aberr…”
BackgroundEndo, Y., Suzuki, K., Kimura, Y., Tamaki, S., Aizawa, H., Abe, I., Watanabe, F., Kato, T., Saito, M., Futsuhara, K., et al. (2022) · International Journal of Oncology · doi:10.3892/ijo.2022.5351 · Cited by 13
“Epigenetic alterations are among the most common features of human cancers and are associated with cancer develop‐ ment and progression (17,18).”
BackgroundMethodMagi, A., Mattei, G., Mingrino, A., Caprioli, C., Ronchini, C., Frigè, G., Semeraro, R., Bolognini, D., Rambaldi, A., Candoni, A., et al. (2023) · Communications Biology · doi:10.1038/s42003-023-04756-8 · Cited by 16
“49) in all the three patients.”
InfluentialFalcone, M., Salhia, B., Halbert, C. H., Torres, E. T. R., Stewart, D. B., Stern, M. C., & Lerman, C. E. (2024) · Cancer Research · doi:10.1158/0008-5472.can-24-1359 · Cited by 17
DNA 5mC methylation inhibits the formation of G-quadruplex structures in the genome
Niu, K., Xiang, L., Li, X., Li, X., Li, Y., Zhang, C., Liu, J., Zhang, X., Peng, Y., Xu, G., et al. (2025) · Genome biology · doi:10.1186/s13059-025-03678-4 · Cited by 20
“A reduced level of genome-wide methylation is a typical feature of oncogenesis [38– 42] and allows to test the negative correlation between DNA 5mC methylation and G4 quantitatively at a global level.”
Epigenetic diversity in hematopoietic neoplasms
Shaknovich, R., De, S., & Michor, F. (2014) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2014.09.003 · Cited by 16
Molecular approaches to equine sarcoids
Semik‐Gurgul, E. (2020) · Equine Veterinary Journal · doi:10.1111/evj.13322 · Cited by 14
Suzuki, K. (2012) · Oncology Reports · doi:10.3892/or.2012.1718 · Cited by 14
“Recent experimental studies in mouse models have provided new insight into cancer development by demonstrating a link between global hypomethylation and chromosomal instability (11,12).”
Kunze, E., & Schlott, T. (2007) · International Journal of Molecular Medicine · doi:10.3892/ijmm.20.4.557 · Cited by 13
“The significance of DNA hypomethylation remains to be unveiled, however, there is evidence that it may promote tumorigenesis by causing chromosomal instability (36,37).”
Marchesi, I., & Bagell, L. (2013) · InTech eBooks · doi:10.5772/55370 · Cited by 17
“Epigenetic abnormalities lead to altered gene expression and cellular physiology and occur in several pathologies such as cancer [145,146].”
BackgroundGiraldo, A. M., Lynn, J. W., Purpera, M. N., Vaught, T. D., Ayares, D., Godke, R. A., & Bondioli, K. R. (2009) · Reproduction Fertility and Development · doi:10.1071/rd08233 · Cited by 13
Genomic instability of surgical sample and cancer-initiating cell lines from human glioblastoma
Pérez‐García, A., Carrion-Navarro, J., Bosch-Fortea, M., Lazaro-Ibanez, E., Prat-Acin, R., & Ayuso-Sacido, A. (2011) · Frontiers in bioscience · doi:10.2741/3998 · Cited by 13
The silence of the genes: epigenetic disturbances in haematopoietic malignancies
Hackanson, B. W., Guo, Y., & Lübbert, M. (2005) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.9.1.45 · Cited by 15
“In a genetically engineered mouse model, it was shown that mice carrying a hypomorphic DNMT 1 allele, which reduces DNMT 1 expression to 10% of wild-type levels, had substantial genome-wide hypomethylation levels in all tissues, increased genomic instability with a gain of chromosome 15 (10 out of 12 mice) and finally…”
BackgroundMetastasis of Colorectal Cancer
Beauchemin, N., & Huot, J. (2010) · Cancer metastasis · doi:10.1007/978-90-481-8833-8 · Cited by 16
Piyathilake, C. J., Azrad, M., Jhala, D. N., Macaluso, M., Kabagambe, E. K., Brill, I. K., Niveleau, A., Jhala, N. C., & Grizzle, W. E. (2006) · Cancer Biomarkers · doi:10.3233/cbm-2006-2604 · Cited by 13
“[14].”
Roles of retrotransposons in benign and malignant hematologic disease.
Schneider, A. M., Duffield, A. S., Symer, D. E., & Burns, K. H. (2009) · PubMed · Cited by 16
Dakessian, R. M., & Fan, H. (2007) · Virology · doi:10.1016/j.virol.2007.10.035 · Cited by 13
DNA methylation: A promising target for the twenty-first century
Abreu, P. A., Dellamora-Ortiz, G. M., Leão-Ferreira, L. R., Gouveia, M., Braggio, E., Zalcberg, I. R., Santos, D. O., Bourguinhon, S., Cabral, L. M., Rodrigues, C. R., et al. (2008) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.12.8.1035 · Cited by 13
“However, the prophylactic use of these molecules will probably fail since it might impair genomic stability and enhance tumor formation in other tissues such as thymus or soft tissues, especially during long-term treatment [62] .”
BackgroundUnravelling the genetics and epigenetics of the ageing tumour microenvironment in cancer
Easwaran, H., & Weeraratna, A. T. (2025) · Nature reviews. Cancer · doi:10.1038/s41568-025-00868-x · Cited by 18
“This can result in aberrant gene expression and genomic instability 29–31 , potentially promoting tumorigenesis (Fig.”
The splicing regulator SLU7 is required to preserve DNMT1 protein stability and DNA methylation
Recalde, M., Gárate‐Rascón, M., Elizalde, M., Azkona, M., Latasa, M. U., Bárcena‐Varela, M., Sangro, B., Fernández‐Barrena, M. G., Avila, M. A., Arechederra, M., et al. (2021) · Nucleic Acids Research · doi:10.1093/nar/gkab649 · Cited by 14
“Moreover, it is well established that DNA methylation plays a relevant role in maintaining genome stability (7–9).”
How chronic inflammation fuels carcinogenesis as an environmental epimutagen
Liu, Y., Ohashi, Y., & Ushijima, T. (2025) · Discover Oncology · doi:10.1007/s12672-025-02971-9 · Cited by 19
“First, global DNA hypomethylation promoted tumor formation in mice [14, 15], and suppression of aberrant DNA methylation by DNA demethylating agents repressed tumorigenesis in mouse models [16–19].”
Induced pluripotent stem cell technology for dissecting the cancer epigenome
Semi, K., & Yamada, Y. (2015) · Cancer Science · doi:10.1111/cas.12758 · Cited by 13
Lian, S., He, Y., Li, X., Zhao, B., Hou, R., Hu, X., Zhang, L., & Bao, Z. (2015) · Journal of Ocean University of China · doi:10.1007/s11802-015-2507-2 · Cited by 15
Metadata
- Authors
- Gaudet, F., Hodgson, J. G., Eden, A., Jackson-Grusby, L., Dausman, J., Gray, J. W., Leonhardt, H., & Jaenisch, R.
- Affiliations
- Whitehead Institute for Biomedical Research and Department of Biology, Massachusetts Institute of Technology, Cambridge, MA 02142, USA.
- University of California, San Francisco (US)
- Corresponding author
- Jaenisch, Rudolf
- Venue
- Science
- Published
- 2003-04-18
- Volume
- 300
- Issue
- 5618
- Pages
- 489-492
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W1990381590
- Cited by
- 1,499
- References
- 34
- Citations by year
- 2026: 12 · 2025: 25 · 2024: 20 · 2023: 36 · 2022: 40 · 2021: 43 · 2020: 52 · 2019: 50 · 2018: 48 · 2017: 48 · 2016: 63 · 2015: 75 · 2014: 57 · 2013: 94 · 2012: 99
- FWCI
- 34.31
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- MDC Repository (Max-Delbrueck-Center for Molecular Medicine) (submittedVersion)
- Funders
- National Cancer Institute (R01CA087869, CA 87869)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Syndromes and Imprinting
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Chromatin Remodeling and Cancer
- Keywords
- DNA hypomethylation, DNMT1, T-cell lymphoma, tumor induction, epigenetic silencing, chromosomal instability, mouse model
- MeSH terms
- DNA (Cytosine-5-)-Methyltransferase 1, Alleles, Animals, Birth Weight, Cell Transformation, Neoplastic, Chromosome Aberrations, DNA (Cytosine-5-)-Methyltransferases, Heterozygote, Mice, Transgenic, Moloney murine leukemia virus, Trisomy, Virus Activation, Gene Rearrangement, Gene Rearrangement, beta-Chain T-Cell Antigen Receptor, Gene Expression, Gene Expression Regulation, Neoplastic, Genes, myc, Lymphoma, T-Cell, DNA Methylation, Loss of Heterozygosity, Endogenous Retroviruses, Chromosomes, Mammalian, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.